HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS Psychiatric Bulletin Advances in Psychiatric Treatment All RCPsych Journals		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Submit an eLetter Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Kraus, M. S. Articles by Keefe, R. S. E. Search for Related Content PubMed Articles by Kraus, M. S. Articles by Keefe, R. S. E.

Cognition as an outcome measure in schizophrenia

Department of Psychiatry and Behavioral Sciences, Duke University School of Medicine, Durham, North Carolina, USA

Correspondence: Dr Richard Keefe, Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, P.O. Box 3270, Durham, NC 27710, USA. Email: richard.keefe{at}duke.edu

Declaration of interest R.S.E.K. receives royalties from sales of the Brief Assessment of Cognition in Schizophrenia (BACS) battery and the MATRICS Consensus Battery (MCCB). He is a member of the MATRICS Neurocognition Committee and Director of the TURNS Chief Neuropsychologists Group. He receives consultancy fees from several pharmaceutical companies.

Background Cognitive deficits are a core feature of schizophrenia. These deficits are not caused by medication or symptoms, and have a dramatic negative effect on real-world functioning.

Aims To critically examine a selection of the most common batteries used to assess cognition in schizophrenia.

Method Literature review of cognitive assessment batteries for use in schizophrenia.

Results A wide variety of neurocognitive test batteries have been developed or adapted to assess cognition in schizophrenia. These differ in time requirements, repeatability, ease of administration, degree of face validity, availability of co-normative data and degree to which results can be parsed into separate domains of cognitive functioning. The most appropriate depends on the setting and the question being addressed.

Conclusions Cognitive outcome measures have reshaped our understanding of schizophrenia and will be essential tools for unravelling the aetiology of the disease and designing more effective interventions.

This article has been cited by other articles:

				T. Burns Evolution of outcome measures in schizophrenia The British Journal of Psychiatry, August 1, 2007; 191(50): s1 - s6. [Abstract] [Full Text] [PDF]